The Effects of Fenofibric Acid Alone and With Statins on the Prevalence of Metabolic Syndrome and Its Diagnostic Components in Patients With Mixed Dyslipidemia

OBJECTIVE: To compare fenofibric acid (FA) + statin to respective monotherapies on the prevalence of metabolic syndrome and its diagnostic components in patients with mixed dyslipidemia. RESEARCH DESIGN AND METHODS: Post hoc analysis of over 2,000 metabolic syndrome patients administered either FA +...

Descripción completa

Detalles Bibliográficos
Autores principales: Bays, Harold E., Roth, Eli M., McKenney, James M., Kelly, Maureen T., Thakker, Kamlesh M., Setze, Carolyn M., Obermeyer, Katie, Sleep, Darryl J.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928374/
https://www.ncbi.nlm.nih.gov/pubmed/20573750
http://dx.doi.org/10.2337/dc10-0357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928374/
https://www.ncbi.nlm.nih.gov/pubmed/20573750
http://dx.doi.org/10.2337/dc10-0357

Ejemplares similares